Showing 3 posts of 3 posts found.


Vaxart shares topline data from phase 2 study of norovirus vaccine candidate

September 8, 2023
Research and Development Infections and infestations, Vaccine, Vaxart, norovirus

Vaxart has announced topline data from its phase 2 challenge study which assessed its oral tablet monovalent norovirus vaccine candidate. …


Takeda begins world’s first norovirus vaccine field trial

June 22, 2016
Research and Development Takeda, Vaccine, norovirus

Takeda Pharmaceuticals (TSE: 4502) has announced that the first patient has received a dosage of their norovirus vaccine candidate, TAK-214, …

Takeda HQ image

Takeda to buy LigoCyte for $60 million

October 8, 2012
Sales and Marketing LigoCyte, Takeda, norovirus

Takeda Pharmaceutical Company is to pay $60 million upfront to buy private US biopharma firm LigoCyte Pharmaceuticals in the next …

Latest content